A detailed history of Creative Planning transactions in Glaukos Corp stock. As of the latest transaction made, Creative Planning holds 12,643 shares of GKOS stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,643
Previous 7,706 64.07%
Holding current value
$2.03 Million
Previous $912,000 80.59%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$113.62 - $135.39 $560,941 - $668,420
4,937 Added 64.07%
12,643 $1.65 Million
Q2 2024

Aug 15, 2024

BUY
$89.48 - $118.35 $385,569 - $509,970
4,309 Added 126.85%
7,706 $912,000
Q1 2024

May 10, 2024

BUY
$76.4 - $96.33 $259,530 - $327,233
3,397 New
3,397 $320,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.63B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.